A prospective, observational study of third generation EGFR TKI osimertinib therapy in non small cell lung cancer patients
Latest Information Update: 15 Jun 2019
At a glance
- Drugs Osimertinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 15 Jun 2019 New trial record
- 04 Jun 2019 Trial design presented at the 55th Annual Meeting of the American Society of Clinical Oncology.